Baird analyst Joe Vruwink lowered the firm’s price target on Veeva (VEEV) to $245 from $251 and keeps an Outperform rating on the shares. The firm said after Veeva raised guidance last quarter, the stock has not followed normal post-raise pattern, suggesting investors expect negative estimate revisions to resume.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Walgreens Boots Alliance (NASDAQ:WBA) Announces Partnership with Veeva Systems
- Walgreens Boots Alliance, Veeva announce strategic partnership
- Exane starts security software group with three Outperform ratings
- Veeva initiated with an Outperform at Exane BNP Paribas
- Veeva announces 18 of top 20 medtech companies use its Cloud applications